T P Obrenovitch. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Amyotrophic Lateral Sclerosis/drug therapyAmyotrophic Lateral Sclerosis/metabolismAmyotrophic Lateral Sclerosis/physiopathologyClinical Trials as TopicExcitatory Amino Acid Antagonists/therapeutic useGlutamic Acid/drug effectsGlutamic Acid/metabolismHumansNeuroprotective Agents/pharmacologyNeuroprotective Agents/therapeutic useRiluzole/pharmacologyRiluzole/therapeutic useSynaptic Transmission/drug effects
Substances： See more » Excitatory Amino Acid AntagonistsNeuroprotective AgentsGlutamic AcidRiluzole
Year: 1998 PMID： 9509893 DOI： 10.1016/s0165-6147(97)01124-3
Source DB: PubMed Journal: Trends Pharmacol Sci ISSN： 0165-6147 Impact factor: 14.819